<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
VTRS
Viatris
$
()


  • Early notable gainers among liquid option names on April 3rd

    4/3/2024 - 09:56am
  • Ocuphire Pharma announces U.S. commercial launch of RYZUMVI

    4/1/2024 - 07:16am
  • Viatris announces U.S. commercial launch of Ryzumvi

    4/1/2024 - 07:05am
  • Viatris price target raised by $2 at Piper Sandler, here's why

    3/28/2024 - 06:41am
  • Viatris call volume above normal and directionally bullish

    3/15/2024 - 11:45am
  • Viatris sees FY24 adjusted EPS $2.70-$2.85, consensus $2.81

    2/28/2024 - 06:40am
  • Viatris reports Q4 EPS (64c), consensus 65c

    2/28/2024 - 06:37am
  • Viatris, Idorsia enter agreements for global research and development

    2/28/2024 - 05:58am
  • Greenlight buys Alight, exits Southwestern in Q4

    2/14/2024 - 16:43pm
  • Viatris call volume above normal and directionally bullish

    1/31/2024 - 11:45am
  • Viatris put volume heavy and directionally bearish

    1/29/2024 - 14:55pm
  • Viatris price target raised by $1 at BofA, here's why

    1/29/2024 - 07:00am
  • Viatris call volume above normal and directionally bullish

    1/23/2024 - 15:05pm
  • Viatris call volume above normal and directionally bullish

    1/22/2024 - 14:05pm
  • Greenlight announced new Alight, Viatris positions, Bloomberg says

    1/22/2024 - 11:46am
dynamic_feed Breaking News